Search by Drug Name or NDC
NDC 76204-0026-02 Arformoterol Tartrate Inhalation Solution 15 ug/2mL Details
Arformoterol Tartrate Inhalation Solution 15 ug/2mL
Arformoterol Tartrate Inhalation Solution is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ritedose Pharmaceuticals, LLC. The primary component is ARFORMOTEROL TARTRATE.
MedlinePlus Drug Summary
Arformoterol inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases, which includes chronic bronchitis and emphysema). Arformoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
Related Packages: 76204-0026-02Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Arformoterol Oral Inhalation
Product Information
| NDC | 76204-0026 |
|---|---|
| Product ID | 76204-026_0cf362f1-2a32-f966-e063-6294a90a5871 |
| Associated GPIs | |
| GCN Sequence Number | 061579 |
| GCN Sequence Number Description | arformoterol tartrate VIAL-NEB 15MCG/2ML INHALATION |
| HIC3 | B6Y |
| HIC3 Description | BETA-ADRENERGIC AGENTS, ORALLY INHALED,LONG ACTING |
| GCN | 97366 |
| HICL Sequence Number | 034087 |
| HICL Sequence Number Description | ARFORMOTEROL TARTRATE |
| Brand/Generic | Generic |
| Proprietary Name | Arformoterol Tartrate Inhalation Solution |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Arformoterol Tartrate Inhalation Solution |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | ug/2mL |
| Substance Name | ARFORMOTEROL TARTRATE |
| Labeler Name | Ritedose Pharmaceuticals, LLC |
| Pharmaceutical Class | Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214736 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76204-0026-02 (76204002602)
| NDC Package Code | 76204-026-02 |
|---|---|
| Billing NDC | 76204002602 |
| Package | 60 POUCH in 1 CARTON (76204-026-02) / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE |
| Marketing Start Date | 2023-02-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.35242 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | ARFORMOTEROL 15 MCG/2 ML SOLN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis